Skip to main content
Equibles

XTLB · Xtl Biopharmaceuticals Ltd · Analyst Estimates

Track XTLB — free

Use XTLB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XTLB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.70 -0.03 (-1.45%) At close · Nov 4
Rebalance outlook locked
Market Cap
$4.18M
Shares
2.46M
Volume · Nov 4 9546 Avg daily vol (3M) 8509

Analyst Estimates

Compare analyst forecasts for Xtl Biopharmaceuticals Ltd across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 16:52 UTC · Publication dates shown per estimate · 2 metric / period groups

FY ending 2016-12-31

Analyst estimates for FY ending 2016-12-31
Metric Low Average High Analyst count
Revenue
Publication date not stated
0.00
0.00
0.00
0

Q ending 2016-06-30

Analyst estimates for Q ending 2016-06-30
Metric Low Average High Analyst count
Revenue
Publication date not stated
0.00
0.00
0.00
0
Key facts CIK 1023549 CUSIP 98386D406 13F (30d) 1 filings 1 filers Visit website Investor relations